North America Clinical Diagnostics Market 2022-2031 by Test (Lipid Panel, Infectious Disease Testing, Liver Panel, CBC), Product (Instruments, Assay Kits & Reagents, Software & Services), Indication (Cardiovascular, Cancer, Infectious Disease), Patient Gender (Male, Female), Age Group (44 and below, 45-64, 65 and over), End User, and Country: Trend Forecast and Growth Opportunity
- Report ID: 29758
- Date: Jun, 2022
- Pages: 108
- Category: Healthcare & Pharmaceuticals
North America clinical diagnostics market is projected to grow by 6.6 % annually in the forecast period and reach $53,670.4 million by 2031, driven by the rising patient awareness and rising demand for high-quality care amid the COVID-19 pandemic, growing healthcare spend, technological advancement, benefits of clinical diagnostics such as quick test results and easy procedure, increasing prevalence of chronic diseases caused due to sedentary lifestyle such as diabetes, cardiovascular diseases, high blood pressure, lipid disorders, kidney diseases and cancer.
Highlighted with 23 tables and 58 figures, this 108-page report “North America Clinical Diagnostics Market 2021-2031 by Test (Lipid Panel, Infectious Disease Testing, Liver Panel, CBC), Product (Instruments, Assay Kits & Reagents, Software & Services), Indication (Cardiovascular, Cancer, Infectious Disease), Patient Gender (Male, Female), Age Group (44 and below, 45-64, 65 and over), End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America clinical diagnostics market and all its sub-segments through extensively detailed classifications.
Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year.
(Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America clinical diagnostics market in every aspect of the classification from perspectives of by Test, Product, Indication, Patient Gender, Age Group, End User, and Country.
Based on Test, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Lipid Panel
• Infectious Disease Testing
• Liver Panel
• Complete Blood Count (CBC)
• Electrolyte Testing
• Renal Panel
• Other Tests
Based on Product, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Instruments
• Assay Kits & Reagents
• Software & Services
By Indication the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Cardiovascular
• Cancer
• Infectious Disease
• Stroke
• Chronic Lower Respiratory Diseases
• Diabetes
• Other Indications
By Patient Gender the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Male Patients
• Female Patients
By Age Group the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Age 44 and below
• Age 45-64
• Age 65 and over
By End User the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Hospital & Clinics Laboratory
• Diagnostic Laboratory
• Point-of-Care Testing
• Other End Users
Geographically, the following national/local markets are fully investigated:
• U.S.
• Canada
• Mexico
For each key country, detailed analysis, and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of key national markets by Test, Product, and Indication over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
• Abbott Laboratories
• Becton, Dickinson and Company
• BioMerieux SA
• Bio-Rad Laboratories Inc.
• Bio-Reference Laboratories
• Bioscientia Healthcare
• Charles River Laboratories
• Danaher Corporation
• Hoffmann-La Roche AG
• Hologic Inc.
• Qiagen NV
• Siemens Healthcare
• Thermo Fisher Scientific
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 13
1.2.6 Market Size/Share Estimation 14
1.2.7 Research Limitations 15
1.3 Executive Summary 16
2 Market Overview and Dynamics 19
2.1 Market Size and Forecast 19
2.1.1 Impact of COVID-19 on World Economy 20
2.1.2 Impact of COVID-19 on the Market 22
2.2 Major Growth Drivers 24
2.3 Market Restraints and Challenges 30
2.4 Emerging Opportunities and Market Trends 33
2.5 Porter’s Fiver Forces Analysis 37
3 Segmentation of North America Market by Test 41
3.1 Market Overview by Test 41
3.2 Lipid Panel 43
3.3 Infectious Disease Testing 44
3.4 Liver Panel 45
3.5 Complete Blood Count (CBC) 46
3.6 Electrolyte Testing 47
3.7 Renal Panel 48
3.8 Other Tests 49
4 Segmentation of North America Market by Product 50
4.1 Market Overview by Product 50
4.2 Instruments 52
4.3 Assay Kits & Reagents 53
4.4 Software & Services 54
5 Segmentation of North America Market by Indication 55
5.1 Market Overview by Indication 55
5.2 Cardiovascular 57
5.3 Cancer 58
5.4 Infectious Disease 59
5.5 Stroke 60
5.6 Chronic Lower Respiratory Diseases 61
5.7 Diabetes 62
5.8 Other Indications 63
6 Segmentation of North America Market by Patient Gender 64
6.1 Market Overview by Patient Gender 64
6.2 Male Patients 66
6.3 Female Patients 67
7 Segmentation of North America Market by Age Group 68
7.1 Market Overview by Age Group 68
7.2 Age 44 and below 70
7.3 Age 45-64 71
7.4 Age 65 and over 72
8 Segmentation of North America Market by End User 73
8.1 Market Overview by End User 73
8.2 Hospital & Clinics Laboratory 75
8.3 Diagnostic Laboratory 76
8.4 Point-of-Care Testing 77
8.5 Other End Users 78
9 North America Market 2021-2031 by Country 79
9.1 Overview of North America Market 79
9.2 U.S. 82
9.3 Canada 86
9.4 Mexico 88
10 Competitive Landscape 90
10.1 Overview of Key Vendors 90
10.2 New Product Launch, Partnership, Investment, and M&A 93
10.3 Company Profiles 94
Abbott Laboratories 94
Becton, Dickinson and Company 96
BioMerieux SA 97
Bio-Rad Laboratories Inc. 98
Bio-Reference Laboratories 99
Bioscientia Healthcare 100
Charles River Laboratories 101
Danaher Corporation 102
Hoffmann-La Roche AG 103
Hologic Inc. 104
Qiagen NV 105
Siemens Healthcare 106
Thermo Fisher Scientific 107
RELATED REPORTS 108
List of Tables
Table 1. Snapshot of North America Clinical Diagnostics Market in Balanced Perspective, 2021-2031 17
Table 2. World Economic Outlook, 2021-2031 21
Table 3. World Health Spending by Region, $ bn, 2013-2020 29
Table 4. Main Product Trends and Market Opportunities in North America Clinical Diagnostics Market 33
Table 5. North America Clinical Diagnostics Market by Test, 2021-2031, $ mn 41
Table 6. North America Clinical Diagnostics Market by Product, 2021-2031, $ mn 50
Table 7. North America Clinical Diagnostics Market by Indication, 2021-2031, $ mn 55
Table 8. North America Clinical Diagnostics Market by Patient Gender, 2021-2031, $ mn 64
Table 9. North America Clinical Diagnostics Market by Age Group, 2021-2031, $ mn 68
Table 10. North America Clinical Diagnostics Market by End User, 2021-2031, $ mn 73
Table 11. North America Clinical Diagnostics Market by Country, 2021-2031, $ mn 80
Table 12. U.S. Clinical Diagnostics Market by Test, 2021-2031, $ mn 85
Table 13. U.S. Clinical Diagnostics Market by Product, 2021-2031, $ mn 85
Table 14. U.S. Clinical Diagnostics Market by Indication, 2021-2031, $ mn 85
Table 15. Canada Clinical Diagnostics Market by Test, 2021-2031, $ mn 87
Table 16. Canada Clinical Diagnostics Market by Product, 2021-2031, $ mn 87
Table 17. Canada Clinical Diagnostics Market by Indication, 2021-2031, $ mn 87
Table 18. Mexico Clinical Diagnostics Market by Test, 2021-2031, $ mn 89
Table 19. Mexico Clinical Diagnostics Market by Product, 2021-2031, $ mn 89
Table 20. Mexico Clinical Diagnostics Market by Indication, 2021-2031, $ mn 89
Table 21. Abbott Laboratories: Company Snapshot 94
Table 22. Abbott Laboratories: Business Segmentation 95
Table 23. Abbott Laboratories: Product Portfolio 95
List of Figures
Figure 1. Research Method Flow Chart 11
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 14
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 16
Figure 4. North America Clinical Diagnostics Market, 2021-2031, $ mn 19
Figure 5. Impact of COVID-19 on Business 22
Figure 6. Primary Drivers and Impact Factors of North America Clinical Diagnostics Market 24
Figure 7. Leading Causes of Death in the World, 2019-2020, million 27
Figure 8. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 28
Figure 9. World Population 65 and Over, % of Total Population, 1950-2060 28
Figure 10. Primary Restraints and Impact Factors of North America Clinical Diagnostics Market 30
Figure 11. Investment Opportunity Analysis 34
Figure 12. Porter’s Fiver Forces Analysis of North America Clinical Diagnostics Market 37
Figure 13. Breakdown of North America Clinical Diagnostics Market by Test, 2021-2031, % of Revenue 42
Figure 14. North America Addressable Market Cap in 2022-2031 by Test, Value ($ mn) and Share (%) 42
Figure 15. North America Clinical Diagnostics Market by Test: Lipid Panel, 2021-2031, $ mn 43
Figure 16. North America Clinical Diagnostics Market by Test: Infectious Disease Testing, 2021-2031, $ mn 44
Figure 17. North America Clinical Diagnostics Market by Test: Liver Panel, 2021-2031, $ mn 45
Figure 18. North America Clinical Diagnostics Market by Test: Complete Blood Count (CBC), 2021-2031, $ mn 46
Figure 19. North America Clinical Diagnostics Market by Test: Electrolyte Testing, 2021-2031, $ mn 47
Figure 20. North America Clinical Diagnostics Market by Test: Renal Panel, 2021-2031, $ mn 48
Figure 21. North America Clinical Diagnostics Market by Test: Other Tests, 2021-2031, $ mn 49
Figure 22. Breakdown of North America Clinical Diagnostics Market by Product, 2021-2031, % of Sales Revenue 51
Figure 23. North America Addressable Market Cap in 2022-2031 by Product, Value ($ mn) and Share (%) 51
Figure 24. North America Clinical Diagnostics Market by Product: Instruments, 2021-2031, $ mn 52
Figure 25. North America Clinical Diagnostics Market by Product: Assay Kits & Reagents, 2021-2031, $ mn 53
Figure 26. North America Clinical Diagnostics Market by Product: Software & Services, 2021-2031, $ mn 54
Figure 27. Breakdown of North America Clinical Diagnostics Market by Indication, 2021-2031, % of Sales Revenue 56
Figure 28. North America Addressable Market Cap in 2022-2031 by Indication, Value ($ mn) and Share (%) 56
Figure 29. North America Clinical Diagnostics Market by Indication: Cardiovascular, 2021-2031, $ mn 57
Figure 30. North America Clinical Diagnostics Market by Indication: Cancer, 2021-2031, $ mn 58
Figure 31. North America Clinical Diagnostics Market by Indication: Infectious Disease, 2021-2031, $ mn 59
Figure 32. North America Clinical Diagnostics Market by Indication: Stroke, 2021-2031, $ mn 60
Figure 33. North America Clinical Diagnostics Market by Indication: Chronic Lower Respiratory Diseases, 2021-2031, $ mn 61
Figure 34. North America Clinical Diagnostics Market by Indication: Diabetes, 2021-2031, $ mn 62
Figure 35. North America Clinical Diagnostics Market by Indication: Other Indications, 2021-2031, $ mn 63
Figure 36. Breakdown of North America Clinical Diagnostics Market by Patient Gender, 2021-2031, % of Revenue 65
Figure 37. North America Addressable Market Cap in 2022-2031 by Patient Gender, Value ($ mn) and Share (%) 65
Figure 38. North America Clinical Diagnostics Market by Patient Gender: Male Patients, 2021-2031, $ mn 66
Figure 39. North America Clinical Diagnostics Market by Patient Gender: Female Patients, 2021-2031, $ mn 67
Figure 40. Breakdown of North America Clinical Diagnostics Market by Age Group, 2021-2031, % of Revenue 69
Figure 41. North America Addressable Market Cap in 2022-2031 by Age Group, Value ($ mn) and Share (%) 69
Figure 42. North America Clinical Diagnostics Market by Age Group: Age 44 and below, 2021-2031, $ mn 70
Figure 43. North America Clinical Diagnostics Market by Age Group: Age 45-64, 2021-2031, $ mn 71
Figure 44. North America Clinical Diagnostics Market by Age Group: Age 65 and over, 2021-2031, $ mn 72
Figure 45. Breakdown of North America Clinical Diagnostics Market by End User, 2021-2031, % of Revenue 73
Figure 46. North America Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%) 74
Figure 47. North America Clinical Diagnostics Market by End User: Hospital & Clinics Laboratory, 2021-2031, $ mn 75
Figure 48. North America Clinical Diagnostics Market by End User: Diagnostic Laboratory, 2021-2031, $ mn 76
Figure 49. North America Clinical Diagnostics Market by End User: Point-of-Care Testing, 2021-2031, $ mn 77
Figure 50. North America Clinical Diagnostics Market by End User: Other End Users, 2021-2031, $ mn 78
Figure 51. Breakdown of North America Clinical Diagnostics Market by Country, 2021 and 2031, % of Revenue 80
Figure 52. Contribution to North America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 81
Figure 53. U.S. Clinical Diagnostics Market, 2021-2031, $ mn 83
Figure 54. Percent Distribution of the 10 Leading Causes of Death by Gender in United States, 2019, % 83
Figure 55. Percent Distribution of the 10 Leading Causes of Death by Age Group in United States, 2019, % 84
Figure 56. Canada Clinical Diagnostics Market, 2021-2031, $ mn 86
Figure 57. Clinical Diagnostics Market in Mexico, 2021-2031, $ mn 88
Figure 58. Growth Stage of North America Clinical Diagnostics Industry over the Forecast Period 90
Research methodology is mainly referring to the practical how of any offered piece of research. More specifically, it’s all about how a researcher systematically designs a study in order to assure extremely valid as well as reliable results that ultimately address the targets and objectives of the research.
In any formal research including academic journal, article, dissertation and so on, there will be a special section on a research methodology that mainly describes what, by whom, how to gather as well as how to evaluate the data are provided.
This research methodology has been segmented into following types:
Primary Research:
It is said to be original information that the researchers collect for the crucial purposes of answering the research questions of readers with the help of surveys, observations and experiments.
Secondary Research:
The secondary research is the data that has already been collected by various other researchers in the form of government analysis or scientific studies.
Qualitative Research:
It is descriptive and subjective method irrespective of facts. Both observation and description are essential in this type of research methodology. Its main vision is to analyze knowledge, attitudes, behaviours as well as opinions of people related to the topic of any research. This method has been operated through grounded research, case study and actionable research.
Quantitative Research:
It contains several laboratory experiments, basic surveys, mathematical calculations, simulations and so on. The possible measurement, quantity or amount is considered to be a major factor in the quantitative research methodology.
Clients
